Document is current
Any future updates will be listed below
-
Authors
Yost, Kathryn E.
Satpathy, Ansuman T. http://orcid.org/0000-0002-5167-537X
Wells, Daniel K.
Qi, Yanyan
Wang, Chunlin
Kageyama, Robin
McNamara, Katherine L.
Granja, Jeffrey M.
Sarin, Kavita Y. http://orcid.org/0000-0001-5363-3053
Brown, Ryanne A.
Gupta, Rohit K.
Curtis, Christina http://orcid.org/0000-0003-0166-3802
Bucktrout, Samantha L.
Davis, Mark M. http://orcid.org/0000-0001-6868-657X
Chang, Anne Lynn S. http://orcid.org/0000-0002-2869-2147
Chang, Howard Y. http://orcid.org/0000-0002-9459-4393
- License Information
-
More Information
Article History
Received: 18 April 2019
Accepted: 11 June 2019
First Online: 29 July 2019
Competing interests
: H.Y.C. is a co-founder of Accent Therapeutics, Pretzel Therapeutics, and is an advisor for 10x Genomics, Arsenal Biosciences, and Spring Discovery. A.L.S.C. was an advisory board member and clinical investigator for studies sponsored by Merck, Regeneron, Novartis, Galderma and Genentech Roche. A.T.S. and D.K.W. are advisors for Immunai.
